Miconazole Nitrate/Triamcinolone Acetonide/Fradiomycin sulfate

硝基咪康唑/曲安奈德/硫酸新霉素

Report date: 2025/11/14 14:16:49

Base Information

Drug NameMiconazole Nitrate/Triamcinolone Acetonide/Fradiomycin sulfate
Drug Alias Name硝酸咪康唑/醋酸曲安奈德/硫酸新霉素
ClassificationSmall molecules > Steroids
Mechanisms of ActionLanosterol 14α-demethylase inhibitorsGlucocorticoid receptor agonistsBacterial penicillin-binding protein inhibitors
TargetsLanosterol 14α-demethylaseGlucocorticoid receptorBacterial penicillin-binding protein
Therapy Area/IndicationsNeurodermatitisEczemaDermatitis, Seborrheic +[5] 
Global Approved IndicationsNeurodermatitisEczemaDermatitis, Seborrheic +[5] 
Approved Indications in ChinaNeurodermatitisEczemaDermatitis, Seborrheic +[5] 
Original Approved Country/TerritoryMainland China
Original Approved Date1990/01/01
Country/TerritoryMainland China
CombinationsYes Miconazole NitrateTriamcinolone AcetonideFradiomycin sulfate
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesTianjin Tianjiao Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsNeurodermatitisEczemaDermatitis, Seborrheic +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeD01AC52D07BB03D07CB01 +[4] 
Related LinksN/A